Prostate Cancer

News and new technology innovations concerning how imaging technology can help diagnose and treat prostate cancer can be found on this channel.

prostate cancer, radiation therapy, high-dose-rate brachytherapy, HDR, Red Journal study

This is a single-fraction high-dose-rate prostate implant imaging and dosimetry. Image courtesy of Daniel Krauss/American Society for Radiation Oncology (ASTRO)

News | Brachytherapy Systems | March 06, 2017
March 6, 2017 — Results from a new prospective clinical trial indicate high-dose-rate (HDR) brachytherapy administered...
Accuray, CyberKnife system, SBRT, long-term disease control, prostate cancer, ASCO GU study
News | Radiation Therapy | February 17, 2017
February 17, 2017 — Accuray Inc. recently announced data from a prospective, Phase II, 17-center study which showed...
ayDCE software, mpMRI, multiparametric magnetic resonance imaging, prostate MRI, RSNA 2017, AHRA, SIIM
Technology | Magnetic Resonance Imaging (MRI) | February 13, 2017
February 13, 2017 —  aycan recently introduced ayDCE software powered by aycan workstation. The new software helps...
Blue Earth Diagnostics, Axumin, fluciclovine F-18, recurrent prostate cancer, Simens PETNET Solutions, increased patient access
News | Radiopharmaceuticals and Tracers | February 07, 2017
February 7, 2017 — Blue Earth Diagnostics and Siemens’ PETNET Solutions announced that an increasing number of...
recurrent prostate cancer, hormone therapy, radiation therapy, Cedars-Sinai study, New England Journal of Medicine
News | Prostate Cancer | February 03, 2017
February 3, 2017 — Adding hormonal therapy to radiation treatment can significantly improve the average long-term...
PET/CT, primary and metastatic prostate cancer, Journal of Nuclear Medicine study, JNM

Ga-68-BBN PET/CT of a 64-year-old man newly diagnosed with prostate cancer by biopsy. Multiple bone metastasis lesions (arrows) were detected. Image courtesy of Jingjing Zhang, Peking Union Medical College, Beijing, China.

News | Prostate Cancer | February 02, 2017
February 2, 2017 — In the featured article from the February 2017 issue of the Journal of Nuclear Medicine, researchers...
prostate cancer, PI-RADS, best clinical research paper, European Urology
News | Prostate Cancer | January 18, 2017
January 18, 2017 — An article promoting standardized imaging efforts to improve diagnosis and treatment of prostate...
Augmenix, SpaceOAR hydrogel spacer, three-year trial data, Red Journal, prostate cancer radiotherapy
News | Patient Positioning Radiation Therapy | January 16, 2017
January 16, 2017 — Augmenix Inc. announced that the International Journal of Radiation Oncology Biology and Physics (...
News | Radiopharmaceuticals and Tracers | January 06, 2017
January 6, 2017 — New research demonstrates that a novel imaging agent can quickly and accurately detect metastasis of...
MRI-guided focused ultrasound
News | Focused Ultrasound Therapy | December 22, 2016
Insightec Ltd. announced that the Exablate Prostate system received CE Mark for treating locally-confined prostate...
prostate, CT scan, Dave Fornell medical
News | Prostate Cancer | December 22, 2016
Cancer Targeted Technology (CTT), a privately-held Seattle-based biotechnology firm focusing on cancer diagnostics and...
News | Prostate Cancer | December 14, 2016
December 14, 2016 — Cancer Targeted Technology (CTT), a privately-held Seattle-based biotechnology firm focusing on...
Exact Imaging Receives FDA 510(k) Clearance for Its ExactVu Micro-Ultrasound System
News | Prostate Cancer | December 09, 2016
Exact Imaging, a leader in high resolution micro-ultrasound systems enabling real-time imaging and biopsy guidance of...
prostate cancer, PET imaging, Johns Hopkins, Daniel Thorek, 11B6 antibody

Uptake of 89Zr-11B6 in the prostate of a transgenic mouse with prostate cancer. Image courtesy of Daniel Thorek

News | Prostate Cancer | November 30, 2016
November 30, 2016 — An international group of researchers report success in mice of a method of using positron emission...
Augmenix, SpaceOAR System, prostate cancer, new CPT code, AMA, American Medical Association
Technology | Prostate Cancer | November 10, 2016
November 10, 2016 — Augmenix Inc. announced that the American Medical Association (AMA) has granted a Category I,...
News | Prostate Cancer | November 02, 2016
November 2, 2016 — A new report on Swedish men with non-aggressive prostate cancer suggests a lot more American men...
Augmenix, SpaceOAR System, prostate cancer, three-year clinical data results, ASTRO 2016
News | Prostate Cancer | October 27, 2016
October 27, 2016 — Augmenix Inc. announced the three-year results from the SpaceOAR System Prostate Cancer US Pivotal...
intermediate-risk prostate cancer, brachytherapy versus external beam therapy, radiation therapy, RT, ASTRO 2016
News | Brachytherapy Systems | October 25, 2016
October 25, 2016 — For men with intermediate-risk prostate cancer, radiation treatment with brachytherapy alone can...
Axumin, fluciclovine F-18, PET agent, Phase 3 study, recurrent prostate cancer detection, Blue Earth Diagnostics
News | Prostate Cancer | October 25, 2016
October 25, 2016 — Blue Earth Diagnostics Ltd. announced the peer-reviewed publication of results from a Phase 3...
prostate cancer, SBRT, stereotactic body radiotherapy, ASTRO 2016 study, Robert Meier, control, side effects, toxicity
News | Radiation Therapy | October 06, 2016
October 6, 2016 — High-dose stereotactic body radiotherapy (SBRT) for men newly diagnosed with low- or intermediate-...